Literature DB >> 11469285

Is clinic prevalence of ICD-10 hyperkinesis underestimated? Impact of increasing awareness by a questionnaire screen in an UK clinic.

D M Foreman1, D Foreman, M Prendergast, B Minty.   

Abstract

Hyperactivity is common, but its diagnosis is still controversial, with two contending approaches: ADHD from DSM IV and hyperkinesis from ICD-10. The concept of ADHD predicts higher rates, but its use may lead to overmedication. Hyperkinesis usefully indicates medication, but clinics using it may detect many fewer cases, raising the possibility of underdiagnosis. It has never been shown whether this lower rate results from hyperkinesis' criteria, or to the differing methods used to detect hyperactivity in those centres that prefer it. We report a mirror study, examining rates of all types of hyperkinesis before and after the introduction of a preliminary screen (not originally intended to detect hyperkinesis). Its introduction resulted in an increase of detected hyperkinesis from 2% to 25% of the clinic sample with no change in diagnostic criteria. This was independent of any other change in the sample or clinic staff. We conclude that insensitive assessment may be responsible for low rates of diagnosis of ICD-10 hyperkinesis in secondary care clinics.

Entities:  

Mesh:

Year:  2001        PMID: 11469285     DOI: 10.1007/s007870170036

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  10 in total

1.  The association between hyperkinesis and breakdown of parenting in clinic populations.

Authors:  D M Foreman; D Foreman; E B Minty
Journal:  Arch Dis Child       Date:  2005-03       Impact factor: 3.791

2.  Questionnaire-based computational screening of adult ADHD.

Authors:  Arthur Trognon; Manon Richard
Journal:  BMC Psychiatry       Date:  2022-06-15       Impact factor: 4.144

Review 3.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

4.  Can standardized diagnostic assessment be a useful adjunct to clinical assessment in child mental health services? A randomized controlled trial of disclosure of the Development and Well-Being Assessment to practitioners.

Authors:  Tamsin Ford; Anna Last; William Henley; Shelley Norman; Sacha Guglani; Katerina Kelesidi; Anne-Marie Martin; Pippa Moran; Harriett Latham-Cork; Robert Goodman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-08-12       Impact factor: 4.328

5.  How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS).

Authors:  Michael Huss; Heike Hölling; Bärbel-Maria Kurth; Robert Schlack
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-12       Impact factor: 4.785

6.  Geographic analysis of the variation in the incidence of ADHD in a country with free access to healthcare: a Danish cohort study.

Authors:  Kathrine Bang Madsen; Annette Kjær Ersbøll; Jørn Olsen; Erik Parner; Carsten Obel
Journal:  Int J Health Geogr       Date:  2015-08-22       Impact factor: 3.918

7.  Assessing the diagnostic accuracy of the identification of hyperkinetic disorders following the introduction of government guidelines in England.

Authors:  David M Foreman; Tamsin Ford
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-11-04       Impact factor: 3.033

8.  Treatment of adult ADHD: is current knowledge useful to clinicians?

Authors:  Terje Torgersen; Bjørn Gjervan; Kirsten Rasmussen
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

9.  Impact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence.

Authors:  Michael Schlander
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2007-11-15       Impact factor: 3.033

10.  Prediction of 7-year psychopathology from mother-infant joint attention behaviours: a nested case-control study.

Authors:  Clare S Allely; Paul C D Johnson; Helen Marwick; Emma Lidstone; Eva Kočovská; Christine Puckering; Alex McConnachie; Jean Golding; Christopher Gillberg; Philip Wilson
Journal:  BMC Pediatr       Date:  2013-09-24       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.